Thomas C Spelsberg is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of biomedical research, particularly in the development of transgenic non-human animals and methods for detecting breast cancer. With a total of 10 patents to his name, Spelsberg's work has the potential to impact various medical conditions and treatments.

Latest Patents

Among his latest patents, Spelsberg has developed materials and methods related to transgenic TIEG non-human animals. These innovations involve a transgenic non-human mammal whose genome comprises a disrupted TIEG allele. The methods provided are aimed at identifying and characterizing agents that affect conditions related to TIEG activity, such as cardiac hypertrophy and bone formation. Additionally, he has contributed to the treatment of hypertrophic cardiomyopathy. Another significant patent involves TGF-β inducible early factor-1 (TIEF-1) and methods to detect breast cancer. This includes methods to determine TIEF-1 polypeptide or genetic rearrangements in the TIEF-1 gene in a sample, along with specific antibodies and nucleic acid probes for detecting breast cancer in situ in mammalian tissue samples.

Career Highlights

Throughout his career, Spelsberg has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research. His research has been pivotal in advancing our understanding of genetic factors in various diseases.

Collaborations

Spelsberg has collaborated with notable colleagues such as Malayannan Subramaniam and Steven A Harris. Their combined expertise has contributed to the success of his innovative projects.

Conclusion

Thomas C Spelsberg's contributions to biomedical research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in medical treatments and diagnostics.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]